Cargando…
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission
OBJECTIVES: Mycobacterium abscessus complex is responsible for 2.6–13.0% of all non-tuberculous mycobacterial pulmonary infections and these are notoriously difficult to treat due to the complex regimens required, drug resistance and adverse effects. Hence, bacteriophages have been considered in cli...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583746/ https://www.ncbi.nlm.nih.gov/pubmed/37364635 http://dx.doi.org/10.1016/j.cmi.2023.06.026 |
_version_ | 1785122617392365568 |
---|---|
author | Dedrick, Rebekah M. Abad, Lawrence Storey, Nathaniel Kaganovsky, Ari M. Smith, Bailey E. Aull, Haley A. Cristinziano, Madison Morkowska, Anna Murthy, Saraswathi Loebinger, Michael R. Hatfull, Graham F. Satta, Giovanni |
author_facet | Dedrick, Rebekah M. Abad, Lawrence Storey, Nathaniel Kaganovsky, Ari M. Smith, Bailey E. Aull, Haley A. Cristinziano, Madison Morkowska, Anna Murthy, Saraswathi Loebinger, Michael R. Hatfull, Graham F. Satta, Giovanni |
author_sort | Dedrick, Rebekah M. |
collection | PubMed |
description | OBJECTIVES: Mycobacterium abscessus complex is responsible for 2.6–13.0% of all non-tuberculous mycobacterial pulmonary infections and these are notoriously difficult to treat due to the complex regimens required, drug resistance and adverse effects. Hence, bacteriophages have been considered in clinical practice as an additional treatment option. Here, we evaluated antibiotic and phage susceptibility profiles of M. abscessus clinical isolates. Whole-genome sequencing (WGS) revealed the phylogenetic relationships, dominant circulating clones (DCCs), the likelihood of patient-to-patient transmission and the presence of prophages. METHODS: Antibiotic susceptibility testing was performed using CLSI breakpoints (n = 95), and plaque assays were used for phage susceptibility testing (subset of n = 88, 35 rough and 53 smooth morphology). WGS was completed using the Illumina platform and analysed using Snippy/snp-dists and Discovery and Extraction of Phages Tool (DEPhT). RESULTS: Amikacin and Tigecycline were the most active drugs (with 2 strains resistant to amikacin, and one strain with Tigecycline MIC of 4 μg/mL). Most strains were resistant to all other drugs tested, with Linezolid and Imipenem showing the least resistance, at 38% (36/95) and 55% (52/95), respectively. Rough colony morphotype strains were more phage-susceptible than smooth strains (77%—27/35 versus 48%—25/53 in the plaque assays, but smooth strains are not killed efficiently by those phages in liquid infection assay). We have also identified 100 resident prophages, some of which were propagated lytically. DCC1 (20%—18/90) and DCC4 (22%—20/90) were observed to be the major clones and WGS identified 6 events of possible patient-to-patient transmission. DISCUSSION: Many strains of M. abscessus complex are intrinsically resistant to available antibiotics and bacteriophages represent an alternative therapeutic option, but only for strains with rough morphology. Further studies are needed to elucidate the role of hospital-borne M. abscessus transmission. |
format | Online Article Text |
id | pubmed-10583746 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
record_format | MEDLINE/PubMed |
spelling | pubmed-105837462023-10-18 The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission Dedrick, Rebekah M. Abad, Lawrence Storey, Nathaniel Kaganovsky, Ari M. Smith, Bailey E. Aull, Haley A. Cristinziano, Madison Morkowska, Anna Murthy, Saraswathi Loebinger, Michael R. Hatfull, Graham F. Satta, Giovanni Clin Microbiol Infect Article OBJECTIVES: Mycobacterium abscessus complex is responsible for 2.6–13.0% of all non-tuberculous mycobacterial pulmonary infections and these are notoriously difficult to treat due to the complex regimens required, drug resistance and adverse effects. Hence, bacteriophages have been considered in clinical practice as an additional treatment option. Here, we evaluated antibiotic and phage susceptibility profiles of M. abscessus clinical isolates. Whole-genome sequencing (WGS) revealed the phylogenetic relationships, dominant circulating clones (DCCs), the likelihood of patient-to-patient transmission and the presence of prophages. METHODS: Antibiotic susceptibility testing was performed using CLSI breakpoints (n = 95), and plaque assays were used for phage susceptibility testing (subset of n = 88, 35 rough and 53 smooth morphology). WGS was completed using the Illumina platform and analysed using Snippy/snp-dists and Discovery and Extraction of Phages Tool (DEPhT). RESULTS: Amikacin and Tigecycline were the most active drugs (with 2 strains resistant to amikacin, and one strain with Tigecycline MIC of 4 μg/mL). Most strains were resistant to all other drugs tested, with Linezolid and Imipenem showing the least resistance, at 38% (36/95) and 55% (52/95), respectively. Rough colony morphotype strains were more phage-susceptible than smooth strains (77%—27/35 versus 48%—25/53 in the plaque assays, but smooth strains are not killed efficiently by those phages in liquid infection assay). We have also identified 100 resident prophages, some of which were propagated lytically. DCC1 (20%—18/90) and DCC4 (22%—20/90) were observed to be the major clones and WGS identified 6 events of possible patient-to-patient transmission. DISCUSSION: Many strains of M. abscessus complex are intrinsically resistant to available antibiotics and bacteriophages represent an alternative therapeutic option, but only for strains with rough morphology. Further studies are needed to elucidate the role of hospital-borne M. abscessus transmission. 2023-10 2023-06-24 /pmc/articles/PMC10583746/ /pubmed/37364635 http://dx.doi.org/10.1016/j.cmi.2023.06.026 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Dedrick, Rebekah M. Abad, Lawrence Storey, Nathaniel Kaganovsky, Ari M. Smith, Bailey E. Aull, Haley A. Cristinziano, Madison Morkowska, Anna Murthy, Saraswathi Loebinger, Michael R. Hatfull, Graham F. Satta, Giovanni The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
title | The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
title_full | The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
title_fullStr | The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
title_full_unstemmed | The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
title_short | The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
title_sort | problem of mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583746/ https://www.ncbi.nlm.nih.gov/pubmed/37364635 http://dx.doi.org/10.1016/j.cmi.2023.06.026 |
work_keys_str_mv | AT dedrickrebekahm theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT abadlawrence theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT storeynathaniel theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT kaganovskyarim theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT smithbaileye theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT aullhaleya theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT cristinzianomadison theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT morkowskaanna theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT murthysaraswathi theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT loebingermichaelr theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT hatfullgrahamf theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT sattagiovanni theproblemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT dedrickrebekahm problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT abadlawrence problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT storeynathaniel problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT kaganovskyarim problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT smithbaileye problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT aullhaleya problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT cristinzianomadison problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT morkowskaanna problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT murthysaraswathi problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT loebingermichaelr problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT hatfullgrahamf problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission AT sattagiovanni problemofmycobacteriumabscessuscomplexmultidrugresistancebacteriophagesusceptibilityandpotentialhealthcaretransmission |